| Growth and size control during development J Vollmer, F Casares, D Iber Open biology 7 (11), 170190, 2017 | 62 | 2017 |
| The effect of mutations near the T1 copper site on the biochemical characteristics of the small laccase from Streptomyces coelicolor A3 (2) A Prins, L Kleinsmidt, N Khan, B Kirby, T Kudanga, J Vollmer, J Pleiss, ... Enzyme and microbial technology 68, 23-32, 2015 | 49 | 2015 |
| Deciphering the mechanism behind Fibroblast Growth Factor (FGF) induced biphasic signal-response profiles J Kanodia, D Chai, J Vollmer, J Kim, A Raue, G Finn, B Schoeberl Cell Communication and Signaling 12 (1), 1-18, 2014 | 43 | 2014 |
| A quantitative analysis of growth control in the Drosophila eye disc J Vollmer, P Fried, M Sánchez-Aragón, CS Lopes, F Casares, D Iber Development 143 (9), 1482-1490, 2016 | 33 | 2016 |
| Growth control in the Drosophila eye disc by the cytokine Unpaired J Vollmer, P Fried, D Aguilar-Hidalgo, M Sánchez-Aragón, A Iannini, ... Development 144 (5), 837-843, 2017 | 23 | 2017 |
| An unbiased analysis of candidate mechanisms for the regulation of Drosophila wing disc growth J Vollmer, D Iber Scientific reports 6 (1), 1-7, 2016 | 12 | 2016 |
| A Shh/Gli-driven three-node timer motif controls temporal identity and fate of neural stem cells JM Dias, Z Alekseenko, A Jeggari, M Boareto, J Vollmer, M Kozhevnikova, ... Science Advances, 2020 | 11 | 2020 |
| Simulating organogenesis in COMSOL: cell-based signaling models J Vollmer, D Menshykau, D Iber arXiv preprint arXiv:1309.6479, 2013 | 10 | 2013 |
| Modeling the activation of the alternative complement pathway and its effects on hemolysis in health and disease A Caruso, J Vollmer, M Machacek, E Kortvely PLOS Computational Biology 16 (10), e1008139, 2020 | 5 | 2020 |
| A Phase 1 Open-Label, Dose Escalation and Expansion Trial to Investigate the Safety, Pharmacokinetics and Pharmacodynamics of CB307, a Trispecific Humabody® T-cell Enhancer, in … K Hashimoto, AJ Pierce, A Chau, S Archer, P Bartlett, P Lloyd, M Maginn, ... cancer (mCRPC) 1, 2, 2021 | 1 | 2021 |
| Abstract CT206: A phase I open-label, dose escalation and expansion trial to investigate the safety, pharmacokinetics and pharmacodynamics of CB307, a trispecific Humabody T … K Hashimoto, AJ Pierce, A Chau, P Bartlett, P Lloyd, M Maginn, ... Cancer Research 81 (13 Supplement), CT206-CT206, 2021 | | 2021 |
| Abstract PR2: A systems biology approach to elucidating the consequences of complex ternary interactions of heparin, FGF ligands, and FGF receptor on downstream signaling in … DH Chai, J Kim, J Vollmer, A Radivojevic, J Kanodia, M Muda, ... Cancer Research 72 (13 Supplement), PR2-PR2, 2012 | | 2012 |
| Simulating Organogenesis in COMSOL Multiphysics®: Cell-based Signaling Models D Iber, J Vollmer, D Menshykau | | |
